Tarja Linnankivi

4.6k citations
22 papers · 631 indexed · h-index 14
Topics
RNA regulation and disease (5 papers)Mitochondrial Function and Pathology (4 papers)Genomic variations and chromosomal abnormalities (4 papers)

In The Last Decade

Tarja Linnankivi

22 papers receiving 612 citations

Peers

Tarja Linnankivi
Comparison fields: 5 of 59
  • Molecular Biology 424
  • Physiology 158
  • Genetics 142
  • Rheumatology 86
  • Clinical Biochemistry 85
Replace Hamad Alzaidan with:
Hamad Alzaidan Saudi Arabia
Josef Ekstein United States
Morad Khayat Israel
Gerarda Cappuccio Italy
Maja Hempel Germany
Karen R. Armbrust United States
Hanna Mierzewska Poland
Denia Ramirez‐Montealegre United States
Cristina Jou Spain
Yaping Yang United States
Tarja Linnankivi relative to Hamad Alzaidan Saudi Arabia Hamad Alzaidan's profile →
Citations per field
00.5×2.9×
Hamad Alzaidan · 1×
Citations per year

Countries citing papers authored by Tarja Linnankivi

Since Specialization
Citations

This map shows the geographic impact of Tarja Linnankivi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarja Linnankivi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarja Linnankivi more than expected).

Fields of papers citing papers by Tarja Linnankivi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarja Linnankivi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarja Linnankivi. The network helps show where Tarja Linnankivi may publish in the future.

Co-authorship network of co-authors of Tarja Linnankivi

This figure shows the co-authorship network connecting the top 25 collaborators of Tarja Linnankivi. A scholar is included among the top collaborators of Tarja Linnankivi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarja Linnankivi. Tarja Linnankivi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 1
4 8
5 1
6 21
7 1
8 5
9 28
10 90
11 117
12 6
13 38
14 48
15 14
16 48
17 50
18 29
19 17
20 18

About Tarja Linnankivi

Tarja Linnankivi is a scholar working on Ophthalmology, Clinical Biochemistry and Neurology, having authored 22 papers that have together received 631 indexed citations. Recurring topics across this work include RNA regulation and disease (5 papers), Mitochondrial Function and Pathology (4 papers) and Genomic variations and chromosomal abnormalities (4 papers). The work is most often cited by research in Clinical Biochemistry (85 citations), Molecular Biology (424 citations) and Physiology (158 citations). Tarja Linnankivi has collaborated with scholars based in Finland, United States and Netherlands. Frequent co-authors include Leena Valanne, Helena Pihko, Tuula Lönnqvist, Outi Mäkitie, Pentti J. Tienari, Tero Kivelä, Riitta Herva, Leena Vainionpää, Mirja Somer and Pirjo Isohanni. Their work appears in journals such as Blood, Brain and Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026